Cheol-Young Park

47PUBLICATIONS
53CO-AUTHORS
Food engineeringBehavioural epidemiologyMolecular targetsSport and exercise nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Nov 14, 2025
Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial.

Da Hea Seo, Kyung Wan Min, Ho Sang Sohn

|Nov 05, 2025
Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).

Sangmo Hong, Won J Kim, Sungrae Kim

|Aug 31, 2025
Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes.

Young Sang Lyu, Hansol Lee, Kyung-Soo Kim

|Aug 17, 2025
2024 Clinical Practice Guidelines for the Diagnosis and Pharmacologic Treatment of Overweight and Obesity by the Korean Society for the Study of Obesity.

Jae Hyun Bae, Ji-Hee Haam, Eonju Jeon

|Mar 05, 2025
Workplace-based continuous glucose monitoring with structured education for pre-diabetes and type 2 diabetes: A prospective community cohort study.

Ji-Hee Ko, Sun-Joon Moon, Ramzi A Ajjan

|Jan 13, 2025
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter].

Young Sang Lyu, Hongyup Ahn, Sangmo Hong

Pageof 8

Frequent Collaborators

13 joint publications

Kyung-Soo Kim

9 joint publications

Sangmo Hong

6 joint publications

Kyungdo Han

4 joint publications

Young Sang Lyu